Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1979 Jul;10(1):27–31. doi: 10.1128/jcm.10.1.27-31.1979

Variable Neutralization of Several Nonspecific Antibacterial Systems in Fresh, Defibrinated Human Blood by Sodium Polyanetholsulfonate and Sodium Amylosulfate

Walter H Traub a,†, Paula I Fukushima 1
PMCID: PMC273087  PMID: 227919

Abstract

Fresh, defibrinated human blood (80 vol%, i.e., 80% [vol/vol] of a 2-ml final assay volume) from two healthy adult donors killed “delayed serum-sensitive” (DSS) and “promptly serum-sensitive” (PSS) strains of Serratia marcescens, PSS control strain Escherichia coli C, Bacillus subtilis strain ATCC 6633, and Micrococcus lysodeikticus ATCC 4698 in a kinetic manner comparable to that of fresh human serum (80 vol%). However, heat-inactivated (56°C, 30 min), defibrinated human blood revealed markedly reduced or a total lack of β-lysin activity against the B. subtilis assay strain. Similarly, lysozyme activity of defibrinated blood was diminished somewhat by heat treatment, as determined with the M. lysodeikticus assay strain. Addition of 500 μg of sodium polyanetholsulfonate (SPS) per ml to 80 vol% of fresh, defibrinated human blood completely neutralized blood bactericidal activity against all assay strains of S. marcescens, E. coli C, and B. subtilis; however, SPS at this concentration failed to abolish lysozyme activity for prolonged periods of incubation. Addition of 500 μg of sodium amylosulfate (SAS) per ml to 80 vol% of fresh defibtinated human blood resulted in protection of cell inocula of DSS strains of S. marcescens only; SAS failed to protect cell inocula of the PSS strains of S. marcescens, E. coli C, B. subtilis, and M. lysodeikticus for extended periods of observation. Based on these data, it is recommended that blood culture specimens that are first drawn into specimen containers (such as Vacutainer tubes or the like) at the patient's bedside, and which contain ≥250 μg of SPS per ml, be diluted into suitable broth media with at least ≥250 μg of SPS per ml by the receiving laboratory within 2 to 4 h after procurement of the specimen. This procedure would ensure continued, adequate neutralization of the specimen's inherent β-lysin, lysozyme, and complement- and antibody-mediated bactericidal activities.

Full text

PDF
27

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belding M. E., Klebanoff S. J. Effect of sodium polyanetholesulfonate on antimicrobial systems in blood. Appl Microbiol. 1972 Nov;24(5):691–698. doi: 10.1128/am.24.5.691-698.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CAVALLO G., PONTIERI G., IMPERATO S. Interaction between "liquoid" (sodiumpolyanetholsulphonate) and lysozyme in the immune haemolytic reaction. Experientia. 1963 Jan 15;19:36–37. doi: 10.1007/BF02135347. [DOI] [PubMed] [Google Scholar]
  3. Des Prez R. M., Bryan C. S., Hawiger J., Colley D. G. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid. Infect Immun. 1975 Jun;11(6):1235–1243. doi: 10.1128/iai.11.6.1235-1243.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Donaldson D. M., Roberts R. R., Larsen H. S., Tew J. G. Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli. Infect Immun. 1974 Sep;10(3):657–666. doi: 10.1128/iai.10.3.657-666.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Donaldson D. M., Tew J. G. beta-Lysin of platelet origin. Bacteriol Rev. 1977 Jun;41(2):501–513. doi: 10.1128/br.41.2.501-513.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eng J., Holten E. Gelatin neutralization of the inhibitory effect of sodium polyanethol sulfonate on Neisseria meningitidis in blood culture media. J Clin Microbiol. 1977 Jul;6(1):1–3. doi: 10.1128/jcm.6.1.1-3.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eng J., Iveland H. Inhibitory effect in vitro of sodium polyanethol sulfonate on the growth of Neisseria meningitidis. J Clin Microbiol. 1975 May;1(5):444–447. doi: 10.1128/jcm.1.5.444-447.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goodkofsky I., Lepow I. H. Functional relationship of factor B in the properdin system to C3 proactivator of human serum. J Immunol. 1971 Oct;107(4):1200–1204. [PubMed] [Google Scholar]
  9. Graves M. H., Morello J. A., Kocka F. E. Sodium polyanethol sulfonate sensitivity of anaerobic cocci. Appl Microbiol. 1974 Jun;27(6):1131–1133. doi: 10.1128/am.27.6.1131-1133.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hall M. M., Warren E., Ilstrup D. M., Washington J. A., 2nd Comparison of sodium amylosulfate and sodium polyanetholsulfonate in blood culture media. J Clin Microbiol. 1976 Feb;3(2):212–213. doi: 10.1128/jcm.3.2.212-213.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kocka F. E., Arthur E. J., Searcy R. L. Comparative effects of two sulfated polyanions used in blood culture on anaerobic cocci. Am J Clin Pathol. 1974 Jan;61(1):25–27. doi: 10.1093/ajcp/61.1.25. [DOI] [PubMed] [Google Scholar]
  12. Kocka F. E., Arthur E. J., Searcy R. L., Smith M., Grodner B. Clinical evaluation of sodium amylosulfate in human blood cultures. Appl Microbiol. 1973 Sep;26(3):421–422. doi: 10.1128/am.26.3.421-422.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kocka F. E., Magoc T., Searcy R. L. New anticoagulant for combating antibacterial activity of human blood. 1. Proc Soc Exp Biol Med. 1972 Sep;140(4):1231–1234. doi: 10.3181/00379727-140-36648. [DOI] [PubMed] [Google Scholar]
  14. Lowrance B. L., Traub W. H. Inactivation of the bactericidal activity of human serum by liquoid (sodium polyanetholsulfonate). Appl Microbiol. 1969 Jun;17(6):839–842. doi: 10.1128/am.17.6.839-842.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Polley M. J., Nachman R. The human complement system in thrombin-mediated platelet function. J Exp Med. 1978 Jun 1;147(6):1713–1726. doi: 10.1084/jem.147.6.1713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Stuart R. D. The Value of Liquoid for Blood Culture. J Clin Pathol. 1948 Nov;1(5):311–314. [PMC free article] [PubMed] [Google Scholar]
  17. Traub W. H., Fukushima P. I. Neutralization of human serum beta-lysin by sodium polyanetholsulfonate and sodium amylosulfate. J Clin Microbiol. 1979 Jul;10(1):19–26. doi: 10.1128/jcm.10.1.19-26.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Traub W. H., Fukushima P. I. Neutralization of human serum lysozyme by sodium polyanethol sulfonate but not by sodium amylosulfate. J Clin Microbiol. 1978 Sep;8(3):306–312. doi: 10.1128/jcm.8.3.306-312.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Traub W. H., Kleber I. Inactivation of classical and alternative pathway-activated bactericidal activity of human serum by sodium polyanetholsulfonate. J Clin Microbiol. 1977 Mar;5(3):278–284. doi: 10.1128/jcm.5.3.278-284.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Traub W. H., Kleber I. Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens. Infect Immun. 1976 May;13(5):1343–1346. doi: 10.1128/iai.13.5.1343-1346.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Traub W. H., Lowrance B. L. Anticomplementary, anticoagulatory, and serum-protein precipitating activity of sodium polyanetholsulfonate. Appl Microbiol. 1970 Sep;20(3):465–468. doi: 10.1128/am.20.3.465-468.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Traub W. H. Studies on neutralization of human serum bactericidal activity by sodium amylosulfate. J Clin Microbiol. 1977 Aug;6(2):128–131. doi: 10.1128/jcm.6.2.128-131.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wilkins T. D., West S. E. Medium-dependent inhibition of Peptostreptococcus anaerobius by sodium polyanetholsulfonate in blood culture media. J Clin Microbiol. 1976 Apr;3(4):393–396. doi: 10.1128/jcm.3.4.393-396.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES